A federal judge on Tuesday issued a final judgment in favor of Ortho-McNeil Pharmaceutical Inc. in the company’s patent infringement fight over a generic version of its blockbuster epilepsy drug.
Seeking a high profile review of the 12-year old Markman rule, biotech company Amgen Inc. asked the U.S. Supreme Court on Thursday to decide whether a federal appeals court should give deference to findings made by a trial court during claim construction.
Holland & Knight LLP has bolstered its national health law practice with the addition of Anne Murphy as partner and chair of its Chicago health law team, marking its eighth acquisition in the past year.
Drug maker Shire PLC has added to its hit list of generic drug companies, claiming Actavis Group hf infringed its patents covering hyperactivity drug Adderall XR.
A U.S. federal judge has ordered two generic drug makers to pay $16.8 million in legal fees to Takeda Pharmaceutical Co Ltd. for their “exceptional misconduct and bad faith” during a patent challenge last year.
The U.S. Food and Drug Administration released draft guidelines Wednesday that would keep individuals with interests of over $50,000 in drug and medical device companies from participating in the agency’s advisory committees.
Charity group Oxfam International has blasted Abbott Laboratories for its recent decision to halt the launch of new medicines in Thailand, urging the pharmaceutical giant not to “abandon the sick people in Thailand.”
Japanese drug maker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement lawsuit against Barr Pharmaceuticals Inc. over its plan to manufacture a generic version of Otsuka’s schizophrenia drug, Abilify.
A former marketing vice president at Pfizer Inc. is appealing the dismissal of his whistleblower lawsuit accusing the pharmaceutical giant of illegally marketing a successful biotechnology drug, human growth hormone Genotropin.
A New Jersey federal court has rejected a challenge by Israeli generics maker Teva Pharmaceuticals to Pfizer’s blockbuster painkiller Celebrex, Pfizer said Tuesday.
A prominent doctors’ group has asked the U.S. Department of Justice to block UnitedHealth Group Inc.’s proposed $2.6 billion takeover of Sierra Health Services, claiming it will give the health care company a monopoly in Nevada.
In a blow to Biomet Inc., a federal appeals court ruled Tuesday in favor of rival medical device maker Medtronic in a dispute over patents covering spinal surgery.
A Texas-based medical device company filed a patent infringement suit Monday against Cardinal Health Inc. and Allegiance Corp. over medical devices used to strengthen bones.
A court has denied a preliminary injunction sought by a public interest law firm against the enforcing of bans on health care providers promoting one Medicare plan over another, ruling the organization has no standing to sue.
A district court judge has struck another blow to embattled law firm Milberg Weiss & Bershad LLP, which was ruled inadequate to act as sole lead counsel in a proposed class action securities case against health company Organogenesis.
A court has denied a demand by health food maker Nutraceutical Corp to lift the U.S. drug agency’s blanket ban on its dietary supplements.
Continuing to mull whether to weigh in on the issue of authorized generics, the U.S. Supreme Court asked the federal government Monday for its opinion on whether the judicial body should hear the Tamoxifen Citrate antitrust lawsuits.
Just days after Alexion Pharmaceuticals Inc.’s blood antibody drug Soliris was approved by the United States Food and Drug Administration, two parties have filed a lawsuit claiming the drug infringes on their patents.
A security officer at HealthSouth Corp. who was fired along with the company’s embattled CEO has won a wrongful termination suit against the company, a verdict that came with a $1.9 million payday.
Prolonging a drawn-out legal battle over stent technology, medical device maker Medtronic Inc. has filed a new patent infringement lawsuit against Johnson & Johnson subsidiary Cordis Corp.